Seminars in Hematology
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
View Chart Journal Specifications
- PublisherW B SAUNDERS CO-ELSEVIER INC
- LanguageEnglish
- FrequencyQuarterly
- LanguageEnglish
- FrequencyQuarterly
- Publication Start Year1964
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating | Months | % Papers published |
|---|---|
| 0-3 | 78% |
| 4-6 | 22% |
| 7-9 | 0% |
| >9 | 0% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Seminars in Hematology been publishing? 
The Seminars in Hematology has been publishing since 1964 till date.
How frequently is the Seminars in Hematology published?
Seminars in Hematology is published Quarterly.
What is the H-index. SNIP score, Citescore and SJR of Seminars in Hematology?
Seminars in Hematology has a H-index score of 100, Citescore of 6.8, SNIP score of 1.18, & SJR of Q1
Who is the publisher of Seminars in Hematology?
The publisher of Seminars in Hematology is W B SAUNDERS CO-ELSEVIER INC.
How can I view the journal metrics of Seminars in Hematology on editage?
For the Seminars in Hematology metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Seminars in Hematology?
The eISSN number is 1532-8686 and pISSN number is 0037-1963 for Seminars in Hematology.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Hematological Diseases, Central nervous system, Cancer immunotherapy, Peripheral T-cell lymphoma, T-cell lymphoma, Genetic variants, Chimeric antigen receptor, Adult patients, Antitumor activity, Minimal residual disease, Epigenetic therapy, Peripheral blood, Bone marrow, Cutaneous T-cell lymphoma, Refractory Peripheral T-cell Lymphoma, Chimeric Antigen Receptor T-Cell Therapy, Complete response, Antitumor response, Blinatumomab, Lenalidomide.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.